Yujuan Guan

6.3k total citations
20 papers, 344 citations indexed

About

Yujuan Guan is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Yujuan Guan has authored 20 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 11 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Yujuan Guan's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (7 papers). Yujuan Guan is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (7 papers). Yujuan Guan collaborates with scholars based in China, United States and Canada. Yujuan Guan's co-authors include Feng Li, Zhiwei Xie, Linghua Li, Fengyu Hu, Chunyan Wen, Xilong Deng, Weiyin Lin, Weiping Cai, Jian Wang and Fuchun Zhang and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Medical Virology.

In The Last Decade

Yujuan Guan

17 papers receiving 336 citations

Peers

Yujuan Guan
Lisi Deng China
Weiyin Lin China
Jiandan Qian China
Anna Garratt United Kingdom
Zhongfang Yan China
Kawthar Mohamed Iran
Elizabeth A. LaMere United States
Gong Shen United States
Qin Mao China
Lisi Deng China
Yujuan Guan
Citations per year, relative to Yujuan Guan Yujuan Guan (= 1×) peers Lisi Deng

Countries citing papers authored by Yujuan Guan

Since Specialization
Citations

This map shows the geographic impact of Yujuan Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujuan Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujuan Guan more than expected).

Fields of papers citing papers by Yujuan Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujuan Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujuan Guan. The network helps show where Yujuan Guan may publish in the future.

Co-authorship network of co-authors of Yujuan Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Yujuan Guan. A scholar is included among the top collaborators of Yujuan Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujuan Guan. Yujuan Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Xieer, Qiaoqiao Chen, Hong Tang, et al.. (2025). Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus Infection. Journal of Clinical and Translational Hepatology. 0(0). 0–0.
2.
Wang, Yipeng, et al.. (2025). [Clinical research progress in different stages of recompensated cirrhosis].. PubMed. 33(8). 715–720.
3.
Xie, Zhiwei, Yang Xia, Chunlan Zhang, et al.. (2022). Efficacy and safety of direct‐acting antiviral therapies and baseline predictors for treatment outcomes in hepatitis C patients: A multicenter, real‐world study in Guangdong, China. Journal of Medical Virology. 94(9). 4459–4469. 2 indexed citations
4.
Deng, Haohui, Fengxia Guo, Linghua Li, et al.. (2021). Dynamic changes of HCV genomes under selective pressure from DAAs therapy in relapsed patients. Virus Research. 302. 198453–198453. 1 indexed citations
5.
6.
Li, Yueping, Zhiwei Xie, Weiyin Lin, et al.. (2020). Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial. Med. 1(1). 105–113.e4. 227 indexed citations
7.
Zheng, Wei, et al.. (2020). CT phenotypes in mild-to-moderate chronic obstructive pulmonary disease: difference before and after the age of 60 years. Clinical Radiology. 76(4). 273–280. 1 indexed citations
8.
Liao, Baolin, Zhi-Peng Liu, Linghua Li, et al.. (2020). Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. International Journal of Medical Sciences. 18(1). 29–41. 23 indexed citations
9.
Lei, Chunliang, Weiyin Lin, Xilong Deng, et al.. (2020). Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China. Journal of Clinical Virology. 133. 104661–104661. 9 indexed citations
10.
11.
Gao, Ming, Chengqian Feng, Yuan Nie, et al.. (2019). A novel one-step quantitative reverse transcription PCR assay for selective amplification of hepatitis B virus pregenomic RNA from a mixture of HBV DNA and RNA in serum. Archives of Virology. 164(11). 2683–2690. 7 indexed citations
12.
Rao, Huiying, Guangming Li, Yongfeng Yang, et al.. (2019). Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis. Journal of Viral Hepatitis. 27(1). 45–51. 2 indexed citations
13.
Jie, Yusheng, Xiaohong Zhang, Yujuan Guan, et al.. (2019). [Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China].. PubMed. 27(2). 123–127. 1 indexed citations
14.
Fan, Huimin, et al.. (2019). Interferon alpha treatment leads to a high rate of hepatitis B surface antigen seroconversion in Chinese children with chronic hepatitis B. Journal of Viral Hepatitis. 26(S1). 77–84. 13 indexed citations
15.
16.
Wang, Haiying, Zhengwei Wan, Ru Xu, et al.. (2017). A Novel Human Pegivirus, HPgV-2 (HHpgV-1), Is Tightly Associated With Hepatitis C Virus (HCV) Infection and HCV/Human Immunodeficiency Virus Type 1 Coinfection. Clinical Infectious Diseases. 66(1). 29–35. 21 indexed citations
17.
Xie, Zhiwei, Jianping Li, Yujuan Guan, et al.. (2017). [A clinical study of antiviral therapy for patients with compensated hepatitis C cirrhosis].. PubMed. 25(11). 827–833. 2 indexed citations
18.
Guan, Yujuan, et al.. (2015). Vitamin D Potentiates the Inhibitory Effect of MicroRNA‐130a in Hepatitis C Virus Replication Independent of Type I Interferon Signaling Pathway. Mediators of Inflammation. 2015(1). 508989–508989. 9 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisi Deng Breakdown of academic impact, for papers by Weiyin Lin Breakdown of academic impact, for papers by Jiandan Qian Breakdown of academic impact, for papers by Anna Garratt Breakdown of academic impact, for papers by Zhongfang Yan Breakdown of academic impact, for papers by Kawthar Mohamed Breakdown of academic impact, for papers by Elizabeth A. LaMere Breakdown of academic impact, for papers by Gong Shen Breakdown of academic impact, for papers by Qin Mao
Rankless by CCL
2026